Vaxcyte (NASDAQ:PCVX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Vaxcyte (PCVX) operate in?

Vaxcyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vaxcyte Stock (NASDAQ: PCVX) stock price, news, charts, stock research, profile.

Open	$78.83
Close	$75.51
Volume / Avg.	2.76M / 675.84K
Day Range	74.23 - 79.78
52 Wk Range	44.20 - 82.04
Market Cap	$8.22B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	10.3%
Days to Cover	21.6

Recent News

Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says

The global PCV market, valued at ~$8 billion annually, is poised for significant growth, estimated to reach ~$12 billion soon. Market dynamics are shifting towards adults, potentially doubling with the US discussing vaccination age reduction. Prevnar20 dominates with 97% market share in adults, but Vaxcyte's advanced conjugate capabilities present a competitive advantage.

Vandana Singh

Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales

Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Vaxcyte Inc

Sector

Health Care

Industry

Biotechnology

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to tr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vaxcyte (PCVX) stock?

You can purchase shares of Vaxcyte (NASDAQ:PCVX) through any online brokerage.

View our list of the best stock brokerages

Who are Vaxcyte (PCVX) competitors?

Other companies in Vaxcyte’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the target price for Vaxcyte (PCVX) stock?

There is no analysis for Vaxcyte.

What is the forecast for Vaxcyte (PCVX) stock?

Vaxcyte has a consensus price target of $60.25.

Current stock price for Vaxcyte (PCVX)?

The stock price for Vaxcyte (NASDAQ: PCVX) is $75.51 last updated June 28, 2024 at 4:01 PM EDT.

Does Vaxcyte (PCVX) pay a dividend?

There are no upcoming dividends for Vaxcyte.

When is Vaxcyte (NASDAQ:PCVX) reporting earnings?

Vaxcyte’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is Vaxcyte (PCVX) going to split?

There is no upcoming split for Vaxcyte.

What sector and industry does Vaxcyte (PCVX) operate in?

Vaxcyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Vaxcyte

Vaxcyte (PCVX) Forecast